N
Nordic Nanovector ASA
F:8NN
Nordic Nanovector ASA
F:8NN
Price:
0.423
EUR
0.59%
Market Cap:
€99.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nordic Nanovector ASA
F:8NN
|
NO |
|
Encision Inc
OTC:ECIA
|
US |
|
Neffs Bancorp Inc
OTC:NEFB
|
US |
|
UGE International Ltd
XTSX:UGE
|
US |
|
Wentworth Energy Inc
OTC:WNWG
|
US |
|
B
|
Basetrophy Group Holdings Ltd
HKEX:8460
|
HK |
|
Kore Mining Ltd
XTSX:KORE
|
CA |
|
Iluka Resources Ltd
ASX:ILU
|
AU |
|
Canara Bank Ltd
NSE:CANBK
|
IN |
Balance Sheet
Balance Sheet Decomposition
Nordic Nanovector ASA
Nordic Nanovector ASA
Balance Sheet Decomposition is not available for
Nordic Nanovector ASA
Nordic Nanovector ASA
Balance Sheet
Nordic Nanovector ASA
Nordic Nanovector ASA
Currency: NOK
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
743
|
1 018
|
757
|
440
|
471
|
294
|
278
|
99
|
|
| Cash Equivalents |
743
|
1 018
|
757
|
440
|
471
|
294
|
278
|
99
|
|
| Total Receivables |
10
|
16
|
16
|
17
|
22
|
15
|
11
|
10
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
9
|
16
|
16
|
17
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
5
|
7
|
3
|
13
|
3
|
0
|
2
|
1
|
|
| Total Current Assets |
758
|
1 042
|
776
|
470
|
495
|
309
|
291
|
109
|
|
| PP&E Net |
3
|
3
|
4
|
4
|
20
|
6
|
6
|
1
|
|
| PP&E Gross |
3
|
3
|
4
|
4
|
20
|
6
|
6
|
1
|
|
| Accumulated Depreciation |
3
|
4
|
6
|
8
|
21
|
35
|
46
|
29
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
760
N/A
|
1 045
+37%
|
780
-25%
|
474
-39%
|
516
+9%
|
315
-39%
|
297
-6%
|
110
-63%
|
|
| Liabilities | |||||||||
| Accounts Payable |
20
|
53
|
29
|
34
|
46
|
66
|
66
|
9
|
|
| Accrued Liabilities |
23
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
14
|
2
|
6
|
0
|
|
| Other Current Liabilities |
5
|
42
|
68
|
73
|
60
|
60
|
80
|
35
|
|
| Total Current Liabilities |
48
|
95
|
97
|
107
|
120
|
129
|
152
|
44
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
5
|
2
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
4
|
3
|
3
|
5
|
4
|
2
|
|
| Total Liabilities |
48
N/A
|
95
+100%
|
101
+6%
|
110
+9%
|
128
+16%
|
136
+6%
|
156
+15%
|
46
-71%
|
|
| Equity | |||||||||
| Common Stock |
9
|
10
|
10
|
10
|
13
|
16
|
20
|
23
|
|
| Retained Earnings |
265
|
494
|
765
|
240
|
39
|
44
|
10
|
39
|
|
| Additional Paid In Capital |
969
|
1 434
|
1 435
|
593
|
335
|
118
|
111
|
1
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
|
| Total Equity |
713
N/A
|
949
+33%
|
680
-28%
|
363
-47%
|
388
+7%
|
179
-54%
|
141
-21%
|
64
-55%
|
|
| Total Liabilities & Equity |
760
N/A
|
1 045
+37%
|
780
-25%
|
474
-39%
|
516
+9%
|
315
-39%
|
297
-6%
|
110
-63%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
45
|
50
|
50
|
50
|
67
|
80
|
98
|
116
|
|
Switch to:
Switch to:
See Also
Discover More
